ArticleContraception and reproductive medicine2026
One-year discontinuation rate of the combined injectable contraceptive among post-abortion women: a prospective follow-up study in Shanghai, China.
Article in Contraception and reproductive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Early Attrition: Access Barriers as the Leading Documented Reason for Stopping Monthly Norethisterone Enanthate/Estradiol Valerate Among Established Users in China: A Retrospective Cohort Study.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-abortion contraception is important for sexual and reproductive health. Combined injectable contraceptives (CICs) are a class of highly effective and reversible contraceptive methods, yet their utilization remains low in China. This study aimed to assess the discontinuation rate, reported side effects, and contraceptive effectiveness of CIC use among post-abortion women in China.
methodsWe conducted a prospective follow-up study among post-abortion women who received post-abortion care (PAC) services in Shanghai, China, from 2023 to 2024. Post-abortion women who initiated the "Compound Norethisterone Enanthate Injection" (NET-EN 50 mg/ E
resultsA total of 1,156 participants were included. The mean duration of CIC use was 5.73 ± 2.15 months. The one-year discontinuation rate was 98.72% (95% CI: 97.83-99.29). At 6 months, the cumulative user-failure and method-failure rates were 0.49% (95% CI: 0.18-1.30) and 0.12% (95% CI: 0.02-1.13), respectively. Side effects were reported by 331 participants (28.63%), and all had discontinued CIC by the end of follow-up. In univariate analysis, women reporting side effects had a significantly higher discontinuation rate than those without side effects; however, this association was not statistically significant in the multivariable Cox proportional hazards model.
conclusionsThe one-year discontinuation rate of monthly CIC was high among post-abortion women in this study. The findings highlight the importance of continued contraceptive support and timely access to alternative methods during post-abortion care follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.